VerticalNews VerticalNews
VerticalNews VerticalNews VerticalNews VerticalNews     VerticalNews VerticalNews

VerticalNews
Government
Technology
Science
International
Business
Ecology & Environment
Entertainment
Education
VerticalNews
VerticalNews
VerticalNews
VerticalNews

VerticalNews Computers

Welcome to VerticalNews!

RECEIVE OUR FREE NEWSLETTER
ON COMPUTERS

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Clinical Chemistry



New Data from University of Copenhagen Illuminate Research in Clinical Chemistry



August 25th, 2011

According to the authors of recent research from Hvidovre, Denmark, "Reliable individual risk calculation for trisomy (T) 13, 18, and 21 in first-trimester screening depends on good estimates of the medians for fetal nuchal translucency thickness (NT), free beta-subunit of human chorionic gonadotropin (hCG beta), and pregnancy-associated plasma protein-A (PAPP-A) in maternal plasma from unaffected pregnancies. Means and SDs of these parameters in unaffected and affected pregnancies are used in the risk calculation program."

"Unfortunately, our commercial program for risk calculation (Astraia) did not allow use of local medians. We developed 2 alternative risk calculation...

Click here for more articles from Clinical Chemistry


Source: VerticalNews Computers (2011-08-25)

VerticalNews
VerticalNews

VerticalNews
SSL VerticalNews